Electronic Drug Delivery Systems Market Trend, Share, Growth, Size Analysis and Forecast 2032

Electronic Drug Delivery Systems Market Insights

The global Electronic Drug Delivery Systems Market size was valued at USD 11.39 Billion in 2023 and is predicted to reach USD 22.39 Billion by the end of 2032. The market is expected to grow with a CAGR of 7.8% during the forecast period. The report analyzes the global Electronic Drug Delivery Systems Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Electronic Drug Delivery Systems industry.

Request Free Sample

Electronic Drug Delivery Systems Industry Perspective:

The report covers forecasts and analyses for the electronic drug delivery systems market on a global and regional level. The study provides historic data from 2018 along with a forecast from 2024 to 2032 based on revenue (USD Million). The study includes drivers and restraints for the electronic drug delivery systems market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the electronic drug delivery systems market on a global as well as regional level.

In order to give the users of this report a comprehensive view of the electronic drug delivery systems market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein the product and services segment is benchmarked based on their market size, growth rate, and general attractiveness.

Request Free Sample

The report provides a company market share analysis in order to give a broader overview of the key players in the electronic drug delivery systems market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the electronic drug delivery systems market on a global and regional basis.

Electronic Drug Delivery Systems Market:  Growth Factors

Electronic drug delivery systems (EDDS) are an important part of the innovation in the field of drug delivery systems. EDDS are interactive, portable, wirelessly connected, and enable patient-supervised therapy. These factors play a vital role in decreasing overall healthcare expenditures. EDDS has immense potential in the field of targeted drug delivery. By delivering optimum concentrations of doses to specific body parts, targeted drug delivery helps in reducing the dosage frequency of potentially harmful drugs.

Factors such as the growing incidence of target ailments, major advancements in the design of EDDS, increasing prevalence of chronic ailments, and positive reimbursement situation in developed regions will act as major driving factors in the growth of the global electronic drug delivery systems market. The application of EDDS in targeted drug delivery and increasing research and development initiatives will act as an opportunity for the market players in the electronic drug delivery systems market. Nonetheless, the high cost of electronic drug delivery systems, the need for maintenance, and the lack of awareness in low-income countries will restrict the growth of the global electronic drug delivery systems market.

Electronic Drug Delivery Systems Market: Report Scope

Electronic Drug Delivery Systems Market: Segmentation

The global electronic drug delivery systems market has been split into type, indication, and region. Based on type, the electronic drug delivery systems market has been segmented into electronic autoinjectors, electronic wearable infusion pumps, electronic inhalers, and electronic injection pens.

The electronic wearable infusion pumps segment accounted for the highest market share in 2023 due to increasing diabetes incidence and the growing accessibility of commercial infusion pumps. The indication segment has been segmented into multiple sclerosis, diabetes, asthma & COPD, cardiovascular disease, and other indications.

The diabetes segment accounted for the highest market share in 2023 due to an increase in the number of diabetes cases around the world and the launch of new products.

North America will be the leading region during the forecast period. Quick uptake of new technologies, high prevalence of target disorders, easy availability of electronic drug delivery devices, and presence of leading market players will boost the market growth in this region. Europe will be the second largest market.

The major reasons are the existence of skilled physicians, growth in awareness concerning the use of electronic drug delivery devices, high diabetes incidence, and favorable reimbursement setup. The Asia Pacific will proliferate at a speedy rate over the forecast period due to fast technological improvements in the healthcare sector and swelling cases of asthma and other respiratory ailments.

The Latin American market will progress at a noteworthy rate during the estimated period. Middle Eastern and African countries are expected to experience noticeable growth in the projected time frame.

Electronic Drug Delivery Systems Market: Competitive Space

The report also includes detailed profiles of key players such as

• Medtronic plc
• Insulet Corporation
• Merck Group
• Bayer AG
• Novo Nordisk
• AstraZeneca
• United Therapeutics Corporation
• Amgen
• Tandem Diabetes Care 
• among others.

This report segments the Global Electronic Drug Delivery Systems Market as follows:

Global Electronic Drug Delivery Systems Market: By Type

• Electronic Autoinjectors
• Electronic Wearable Infusion Pumps
• Electronic Inhalers
• Electronic Injection Pens

Global Electronic Drug Delivery Systems Market: By Indication

• Multiple Sclerosis
• Diabetes
• Asthma & COPD
• Cardiovascular Disease
• Other Indications

Global Electronic Drug Delivery Systems Market: By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of The Middle East & Africa